Block-T 500 mg/5 ml (IM/IV Injection)
5 ml ampoule: ৳ 50.00 (1 x 3: ৳ 150.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Tranexamic acid |
| Company | Drug international ltd |
| Also available as |
Title
- Block-T Hemostatic Medicine
Categories
- Medicine
- Hemostatic Drugs
- Anti-fibrinolytic Drugs
Description
- A medication used for prophylaxis and therapy of various hemorrhagic conditions in different medical specialties
Dimensions
- N/A
Color Options
- N/A
Functions
- Antifibrinolytic action
- Hemostatic action
- Prophylaxis
- Therapy of hemorrhages
- Inhibition of plasminogen activation
Materials
- Tranexamic Acid (trans-4 aminomethyl-cyclohexanecarboxylic acid)
Technical Specifications
- 10 times more active than conventional hemostatics
- Low acute toxicity
- Non-existent chronic toxicity
- Well absorbed orally
- Excreted mainly by renal route
Design Elements
- Ampoules
- Capsules
Usability Features
- Easy oral administration
- Slow intravenous injection
- Parenteral (intravenous or intramuscular) route administration
Dosage
- Usual dose: 500-1000 mg 3 times daily for adults
- Mean recommended daily doses for prophylaxis
- Increased oral dose for therapy of hemorrhagic manifestations
- Oral administration based on body weight for children
- No reduction in dosage for elderly patients
Interaction
- Incompatibility with penicillins
- Antagonism with thrombolytic drugs
- Increased thrombus formation with estrogen-containing drugs
Contraindications
- Known hypersensitivity
- Thromboembolic disease
- Serious kidney failure
Side Effects
- Sense of fatigue
- Conjunctival irritation
- Nasal blockage
- Itching
- Skin reddening
- Exanthems
- Nausea
- Diarrhea
- Gastric pyrosis
- Postural hypotension
Pregnancy & Lactation
- Avoid use during pregnancy
- Possible transfer into breast milk with low concentration
Precautions & Warnings
- Use in hyperfibrinolysis cases
- Prophylactic treatment timing
- Prolonged therapy for hemorrhages
- Dose adjustment for hematuria
- Caution in renal insufficiency, cardiac, and hepatic conditions
Therapeutic Class
- Anti-fibrinolytic drugs
- Haemostatic drugs
Storage Conditions
- Dry place at 15-30°C
- Away from light
- Keep out of children's reach